LEO III Fund acquires PronoKal Group from Nestlé Health Science to drive Innovation an global growth in ketogenic Nutrition
Munich/Barcelona, Juli 31, 2025 – We’re proud to announce that LEO III Fund has successfully acquired PronoKal Group from Nestlé Health Science. With this acquisition, PronoKal will now operate as an independent company – ready to strengthen its leading position in the fast-growing ketogenic nutrition market. Backed by a strong foundation in science-based, medically supervised nutrition, the company […]

